Finance

Lists
Why is PHAT up 4,28%?
Dive Deeper
PHAT:NASDAQ
Phathom Pharmaceuticals Inc
7,31 $
+4,28%
(+0,30) 1D
7,31 $
0,00% (0,00)
After hours
Closed: 20 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHAT...
Open
7,04 $
High
7,40 $
Low
6,96 $
Mkt. cap
591,39 մլն
Avg. vol.
1,36 մլն
Volume
724,32 հզր
52-wk high
18,31 $
52-wk low
6,52 $
EPS
-1,27 $
Beta
0,50
Shares outstanding
80,90 մլն
No. of employees
371
Open
7,04 $
High
7,40 $
Low
6,96 $
Mkt. cap
591,39 մլն
Avg. vol.
1,36 մլն
Volume
724,32 հզր
52-wk high
18,31 $
52-wk low
6,52 $
EPS
-1,27 $
Beta
0,50
Shares outstanding
80,90 մլն
No. of employees
371
News stories
From web sources and news partners
About Phathom Pharmaceuticals Inc
CEO-
Employees371
Founded2018
HeadquartersFlorham Park, Նյու Ջերսի, Միացյալ Նահանգներ
Sector-
Websitephathompharma.com
Analyst ratings
Based on 7 analysts giving stock ratings to PHAT in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for PHAT in the last 3 months.
Highest
Current 7,31 $
26,00 $ (+255,68%)
Average
19,29 $ (+163,89%)
Lowest
10,00 $ (+36,80%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Caufield
H.C. Wainwright
Buy
Maintained
26,00 $
+255,7%
09/21/2026
Daniel Clark
Leerink Partners
Hold
Initiated
10,00 $
+36,8%
09/09/2026
Jenna Davidner
Barclays
Buy
Maintained
14,00 $
+91,5%
08/17/2026
Chase Knickerbocker
Craig-Hallum
Buy
Reiterated
20,00 $
+173,6%
07/31/2026
Martin Auster
Raymond James
Buy
Maintained
21,00 $
+187,3%
07/31/2026
Yatin Suneja
Guggenheim
Buy
Maintained
22,00 $
+201%
07/31/2026
Joseph Stringer
Needham
Buy
Maintained
22,00 $
+201%
07/30/2026
Paul Choi
Goldman Sachs
Hold
Maintained
-
-
04/30/2026
Last report
30 հլս, 2026 թ.
Fiscal period
Q2 2026
/ -0,09 $
0,00%miss
Revenue / Est. (USD)
74,27 մլն / 73,06 մլն
+1,66%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
49,50 մլն
57,58 մլն
58,30 մլն
74,27 մլն
Cost of goods sold
6,19 մլն
7,65 մլն
12,00 մլն
15,10 մլն
Cost of revenue
6,19 մլն
7,65 մլն
12,00 մլն
15,10 մլն
Research and development expenses
7,03 մլն
7,49 մլն
7,77 մլն
7,81 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
51,56 մլն
48,37 մլն
54,01 մլն
55,33 մլն
Operating expense
58,58 մլն
55,86 մլն
61,78 մլն
63,14 մլն
Total operating expenses
64,78 մլն
63,51 մլն
73,78 մլն
78,24 մլն
Operating income
-15,27 մլն
-5,93 մլն
-15,48 մլն
-3,96 մլն
Other non operating income
-7,00 հզր
-5,00 հզր
-831,00 հզր
-24,00 հզր
EBT including unusual items
-29,97 մլն
-21,15 մլն
-30,37 մլն
-17,58 մլն
EBT excluding unusual items
-29,97 մլն
-21,15 մլն
-30,37 մլն
-17,58 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-29,97 մլն
-21,15 մլն
-30,37 մլն
-17,58 մլն
Net profit margin
-60,55%
-36,73%
-52,09%
-23,67%
Earnings per share
-0,15
-0,08
-0,18
-
Interest and investment income
1,41 մլն
1,20 մլն
1,74 մլն
1,51 մլն
Interest expense
-16,11 մլն
-16,42 մլն
-15,80 մլն
-15,10 մլն
Net interest expenses
-14,70 մլն
-15,22 մլն
-14,06 մլն
-13,59 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-15,12 մլն
-5,80 մլն
-15,37 մլն
-3,85 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps